about
Designing a HER2/neu promoter to drive alpha1,3galactosyltransferase expression for targeted anti-alphaGal antibody-mediated tumor cell killing.[Distribution of human papillomavirus genotypes amongst HIV-negative and HIV-positive women diagnosed with ASC-US cytology. Preliminary data of a local retrospective study].Virological response and resistance mutations to NS3/4A inhibitors in hepatitis C virus-human immunodeficiency virus coinfection.Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM lineImprovement of DNA extraction for human papillomavirus genotyping from formalin-fixed paraffin-embedded tissues.Multicenter quality control of hepatitis C virus protease inhibitor resistance genotypingCD1c-Related DCs that Express CD207/Langerin, but Are Distinguishable from Langerhans Cells, Are Consistently Present in Human TonsilsUnique DNA methylation signature in HPV-positive head and neck squamous cell carcinomas.Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge.Papillomavirus genotyping on formaldehyde fixed paraffin-embedded tissues in vulvar intraepithelial neoplasia.High permissivity of human HepG2 hepatoma cells for influenza viruses.Epigenetic reprogramming of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) in HIV-1-infected CEM T cells.[Analytical performances of real-time PCR by Abbott RealTime CMV with m2000 for the detection of cytomegalovirus in urine].Alteration of CD44 expression in HIV type 1-infected T cell lines.Autoantibodies directed against CD43 molecules with an altered glycosylation status on human immunodeficiency virus type 1 (HIV-1)-infected CEM cells are found in all HIV-1+ individuals.Lymphocytic CD43 and CD45 bear sulfate residues potentially implicated in cell to cell interactions.Easy and fast detection and genotyping of high-risk human papillomavirus by dedicated DNA microarrays.Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death.Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab.HCV/HIV co-infection, HCV viral load and mode of delivery: risk factors for mother-to-child transmission of hepatitis C virus?Inverted conjunctival papilloma: a certainly underestimated high-risk lesion for carcinomatous transformation-a case report.Expression of LSLCL, a new C-type lectin, is closely restricted, in bone marrow, to immature neutrophils.Characterization of a cluster of oncogenic mutations in E6 of a human papillomavirus 83 variant isolated from a high-grade squamous intraepithelial lesionAltered sialylation of alveolar macrophages in HIV-1-infected individualsAn absolute requirement for Fyn in T cell receptor-induced caspase activation and apoptosisInverse proportions of activated and CD4 circulating lymphocytes in AIDS patientsImmunohistochemical and molecular study of severe cervical dysplasia associated with HPV-83Detection of antibodies to hepatitis B core antigen using the Abbott ARCHITECT anti-HBc assay: analysis of borderline reactive seraFirst case report of an acute genotype 3 hepatitis E infected pregnant woman living in South-Eastern France[Hepatitis E initially serologically silent with prolonged evolution in a patient treated for a lymphoma]
P50
Q24810669-E95364EC-F141-47D0-9A17-A5249A9FBC83Q30857301-811FAFB8-FC85-4DC8-B815-C271FC721AA7Q35999442-624E7FD3-FC83-4575-B2E2-DA1A57F71298Q36364056-C7E7219D-2E2B-4269-B2A8-903BE2E2412AQ36574450-C6AF061B-9A6D-4A6D-B20D-AE554DB46D23Q36826639-D38FD0BB-F6F6-4A70-87EE-B39845824FCCQ36932739-45C30401-50F5-4B23-A3C2-6DB4497C4046Q37739301-B3C76268-259A-457A-8889-8697C5BD4931Q38770052-1C4B89C2-76A7-4ED7-8437-3B9E422232FCQ40088330-EEDF0AE1-2025-4300-9DFE-DD01769E8526Q40483839-2A015DB3-E6DC-4660-AAD7-4A389830BC57Q40506938-81FFF51A-166E-4DE7-8DCE-57C538BD12D6Q40735197-4A6B3642-787B-4BAC-A98C-4F099D8635F6Q41150661-A7DFF619-848B-436C-BB4B-D716DF1EFA99Q41295165-D95BFFD8-22D0-4C69-8923-5D9D84D51775Q41390436-AE9119ED-E6A4-473D-A904-EB15D27ACEC3Q44529753-82D6CEA0-08ED-4283-B57B-507D5F248EA1Q44553769-4D485A8B-4E0B-496D-9836-30522F1A4DBFQ45385929-203072B4-40A3-4CF6-8341-F0F9C38AA621Q45401256-771D7B9D-A961-4381-9213-73CCF884F504Q52901520-BD9A3F50-885B-47CD-BEC9-271143C66617Q55035642-055955DD-1606-4F43-81B6-5A487E065EC0Q63681520-C208887F-51C7-4EC4-B20D-318E95B17F73Q73835976-1A106399-1B07-4002-AD06-AE00C4422687Q74299253-01108598-8FC0-4B16-8C3F-BB450A589AA5Q77974221-B6DF76EE-E108-43B9-BAA3-70F8523BDAECQ79614487-2A1C0629-5372-47FD-9319-B5367ED45E62Q82264925-F665CAD2-87F2-4960-B760-CD8ED29BB0F9Q83451570-C554C6F3-DEFC-477E-83CB-9D712963A016Q83841052-BF669179-8DF5-4111-B02D-CA029E2BE520
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Valérie Giordanengo
@ast
Valérie Giordanengo
@en
Valérie Giordanengo
@es
Valérie Giordanengo
@nl
type
label
Valérie Giordanengo
@ast
Valérie Giordanengo
@en
Valérie Giordanengo
@es
Valérie Giordanengo
@nl
prefLabel
Valérie Giordanengo
@ast
Valérie Giordanengo
@en
Valérie Giordanengo
@es
Valérie Giordanengo
@nl
P106
P31
P496
0000-0002-5114-1124